BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17409026)

  • 21. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mantel-Haenszel test statistics for correlated binary data.
    Zhang J; Boos DD
    Biometrics; 1997 Dec; 53(4):1185-98. PubMed ID: 9423245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing the effect of treatment in experiments with correlated binary outcomes.
    Zucker D; Wittes J
    Biometrics; 1992 Sep; 48(3):695-709. PubMed ID: 1420835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Monte Carlo investigation of homogeneity tests of the odds ratio under various sample size configurations.
    Jones MP; O'Gorman TW; Lemke JH; Woolson RF
    Biometrics; 1989 Mar; 45(1):171-81. PubMed ID: 2720050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing the non-unity of rate ratio under inverse sampling.
    Tang ML; Liao YJ; Ng HK; Chan PS
    Biom J; 2007 Aug; 49(4):551-64. PubMed ID: 17621387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On tests of rate ratio under standard inverse sampling.
    Tang ML; Liao YJ; Ng HK
    Comput Methods Programs Biomed; 2008 Mar; 89(3):261-8. PubMed ID: 18164512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing and estimation of proportion (or risk) ratio under the matched-pair design with multiple binary endpoints.
    Lui KJ; Chang KC
    Biom J; 2013 Jul; 55(4):603-16. PubMed ID: 23637017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notes on testing noninferiority in ordinal data under the parallel groups design.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(6):1294-307. PubMed ID: 24138433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes on interval estimation of the attributable risk in cross-sectional sampling.
    Lui KJ
    Stat Med; 2001 Jun; 20(12):1797-809. PubMed ID: 11406842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial.
    Murray DM; Hannan PJ; Pals SP; McCowen RG; Baker WL; Blitstein JL
    Stat Med; 2006 Feb; 25(3):375-88. PubMed ID: 16143991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tests for homogeneity of the risk difference when data are sparse.
    Lipsitz SR; Dear KB; Laird NM; Molenberghs G
    Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials.
    Ukoumunne OC; Forbes AB; Carlin JB; Gulliford MC
    Stat Med; 2008 Nov; 27(25):5143-55. PubMed ID: 18613226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interval estimation of generalized odds ratio in data with repeated measurements.
    Lui KJ
    Stat Med; 2002 Oct; 21(20):3107-17. PubMed ID: 12369085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval estimation of the attributable risk for multiple exposure levels in case-control studies with confounders.
    Lui KJ
    Stat Med; 2003 Aug; 22(15):2443-57. PubMed ID: 12872301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.